Liver Resection Promotes (Regulates) Proinflammatory Cytokines in Patients with Hepatocellular Carcinoma

Table 2

The clinicopathological characteristics of participants.

Age (mean ± SD)	60 ± 2.59
Gender	Female: 7 (46.66); Male: 8 (53.33)
Tumor type	HCC: 15 (100%)
TNM; Primary tumor; Regional lymph nodes; Distant metastasis	T2: 4 (26.66%); T3: 7 (46.66%); T4: 4(26.66%); 0 (0.0%); 0 (0.0%)
Stage	II: 4 (26.66%); IIIA: 7 (46.66%); IIIB: 4 (26.66%)
Tumor size	<2 : 6 (40%); ≤2–5 ≤: 7 (46.66%); 5 >: 2 (13.34%)
Hepatitis B	2 (13.34%)
Smoking history	6 (40%)
Alcohol consumption	44(26.66%)
WBC	9766 ± 1240
Hb (g/dl)	11.67 ± 1.54
Hct (%)	39.45 ± 3.18
FBS (mg/dl)	96.11 ± 7.9
Creatinine (mg/dl)	0.96 ± 0.16
BUN (mg/dl)	15.56 ± 3.19
Urea (mg/dl)	9.67 ± 2.54
AST (U/L)	36.43 ± 3.12
ALT(U/L)	34.8 ± 4.39
Albumin (g/dl)	3.86 ± 0.81
Total bilirubin (mg/dl)	1.06 ± 0.4
PT (seconds)	13.5 ± 1.67
PTT (seconds)	34.1 ± 3.89

TNM staging based on AJCC 8th edition. HCC: hepatocellular carcinoma; Hb: hemoglobin; Hct; hematocrit; FBS: fasting blood sugar; BUN: blood urea nitrogen; AST: aspartate aminotransferase; ALT: alanine transaminase; PT: prothrombin time; PTT: partial thromboplastin time.